A Novel POPDC2 Pathogenic Variant in a Young Patient With Cardiac Conduction Disease and Hypertrophic Cardiomyopathy

Documenti analoghi

• Novel Pathogenic Variant Confirms the Association of REST and Jones Syndrome
  di: Valentina Lodato, et al.
  Pubblicazione: (2025)
• Unique Genetic Profiles in Hypertrophic Cardiomyopathy Patients From São Miguel Island (Azores, Portugal)
  di: Fabiana Duarte, et al.
  Pubblicazione: (2024)
• Ictal Asystole in a Patient With DEE due to an FGF12 Pathogenic Variant: A Reminder to Monitor Cardiac Function
  di: Johanne Piotrowski, et al.
  Pubblicazione: (2025)
• Yield of Genetic Testing in Pediatric Cardiomyopathies: Implications for Novel Therapeutic Options
  di: Adelaide Ballerini, et al.
  Pubblicazione: (2025)
• Functional Characterization and In Silico Prediction Tools Improve the Pathogenicity Prediction of Novel Bile Acid Transporter Variants
  di: Ziyue Peng, et al.
  Pubblicazione: (2025)